Psoriatic Arthritis
Guidelines
EULAR gives pointers on intra-articular injection best practices
A task force based the recommendations on a systematic literature review and two surveys of health professionals and patients to help form expert...
Conference Coverage
New registry focuses on rheumatic immune-related AEs of cancer therapy
Data from the German TRheuMa registry suggest these events are generally mild or moderate, verifiable by CRP level and imaging (but not...
Conference Coverage
Psoriasis topical combination maintenance strategy hits mark in phase 3
The risk of a first relapse during the course of 1 year was 43% lower with the combination foam than in controls.
Conference Coverage
Results from two phase 3 trials of bimekizumab unveiled
Bimekizumab selectively inhibits IL-17A and IL-17F, two key cytokines that drive inflammation and tissue damage across multiple diseases.
Conference Coverage
Entheseal lesions, bone density linked with incident PsA in psoriasis patients
Metacarpal entheseal lesions and low entheseal bone density in patients with psoriasis each linked with increased incident psoriatic arthritis.
Conference Coverage
EULAR’s COVID-19 recommendations offer no surprises
The provisional recommendations cover four themes: general measures and preventing SARS-CoV-2 infection, managing patients without COVID-19 and...
Conference Coverage
Upadacitinib looks effective for psoriatic arthritis
The researchers were “pleasantly surprised by the magnitude and rapidity of effect” of upadacitinib in study participants, demonstrating “a high...
Conference Coverage
Opioid use up after TNF inhibitor for inflammatory arthritis
The findings are an “important reminder” to rheumatologists that they should broaden their consideration of other pain treatments and techniques...
Conference Coverage
Age leads COVID-19 hospitalization risk factors in RMDs
Glucocorticoid use, cardiovascular comorbidity, and male gender were also found to increase the risk of hospitalization from COVID-19 in...
From the Journals
Biologics may carry melanoma risk for patients with immune-mediated inflammatory diseases
“We advocate for more large, well-designed studies of this issue to be performed to help improve certainty,” the researchers said.
Conference Coverage
TNF inhibitor plus methotrexate surpassed methotrexate monotherapy in PsA
Adding a tumor necrosis factor inhibitor to methotrexate tripled attainment of minimal disease activity, compared with intensified methotrexate...